Legionnaire's Disease Beyond the Lungs: A Rare Case of Severe Rhabdomyolysis and Acute Kidney Injury from a Possible Vaping Source.

IF 0.8 Q4 PHARMACOLOGY & PHARMACY
Drew A Wells, John Eick
{"title":"Legionnaire's Disease Beyond the Lungs: A Rare Case of Severe Rhabdomyolysis and Acute Kidney Injury from a Possible Vaping Source.","authors":"Drew A Wells, John Eick","doi":"10.1177/00185787251319309","DOIUrl":null,"url":null,"abstract":"<p><p>Legionnaires' disease (LD), caused by <i>Legionella pneumophila</i>, often presents with pneumonia, gastrointestinal symptoms, and confusion. Severe LD can lead to a triad of pneumonia, rhabdomyolysis, and acute kidney injury (AKI), with less common complications such as liver injury. We report a case of a 32-year-old male with no prior medical history who presented with LD complicated by severe rhabdomyolysis, AKI requiring hemodialysis (HD), and acute liver injury. The patient reported 6 days of gastrointestinal symptoms, reduced mobility, and minimal urine output. The patient also reported a history of vaping. Diagnostic imaging revealed pneumonia and enterocolitis, while laboratory findings included leukocytosis, hyponatremia, significantly elevated creatinine kinase (201 000 U/L), and acute transaminitis. A positive Legionella urine antigen confirmed the diagnosis. Initial treatment with azithromycin for 7 days showed partial improvement; however, clinical and laboratory deterioration necessitated a switch to levofloxacin for an additional 7 days. This case highlights rare, severe multi-organ involvement in LD, with rhabdomyolysis and AKI being particularly pronounced. The possible association between vaping and Legionella infection is explored, given the patient's history of vaping and limited prior documentation of such a link. Prompt recognition, accurate diagnosis, and escalation of therapy are critical in managing severe LD and reducing associated morbidity.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251319309"},"PeriodicalIF":0.8000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826814/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251319309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Legionnaires' disease (LD), caused by Legionella pneumophila, often presents with pneumonia, gastrointestinal symptoms, and confusion. Severe LD can lead to a triad of pneumonia, rhabdomyolysis, and acute kidney injury (AKI), with less common complications such as liver injury. We report a case of a 32-year-old male with no prior medical history who presented with LD complicated by severe rhabdomyolysis, AKI requiring hemodialysis (HD), and acute liver injury. The patient reported 6 days of gastrointestinal symptoms, reduced mobility, and minimal urine output. The patient also reported a history of vaping. Diagnostic imaging revealed pneumonia and enterocolitis, while laboratory findings included leukocytosis, hyponatremia, significantly elevated creatinine kinase (201 000 U/L), and acute transaminitis. A positive Legionella urine antigen confirmed the diagnosis. Initial treatment with azithromycin for 7 days showed partial improvement; however, clinical and laboratory deterioration necessitated a switch to levofloxacin for an additional 7 days. This case highlights rare, severe multi-organ involvement in LD, with rhabdomyolysis and AKI being particularly pronounced. The possible association between vaping and Legionella infection is explored, given the patient's history of vaping and limited prior documentation of such a link. Prompt recognition, accurate diagnosis, and escalation of therapy are critical in managing severe LD and reducing associated morbidity.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Hospital Pharmacy
Hospital Pharmacy PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
0.00%
发文量
63
期刊介绍: Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信